Published in PLoS One on June 14, 2012
Renal dopamine receptors, oxidative stress, and hypertension. Int J Mol Sci (2013) 0.96
The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease. Transl Res (2014) 0.88
Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells. Hypertension (2013) 0.88
Antihypertensive mechanisms of intra-renal dopamine. Curr Opin Nephrol Hypertens (2015) 0.87
Dopamine receptors - IUPHAR Review 13. Br J Pharmacol (2015) 0.87
Sestrin2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of reactive oxygen species production. Hypertension (2014) 0.85
Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation. FASEB J (2013) 0.82
MiR-217 mediates the protective effects of the dopamine D2 receptor on fibrosis in human renal proximal tubule cells. Hypertension (2015) 0.82
Renal dopaminergic system: Pathophysiological implications and clinical perspectives. World J Nephrol (2015) 0.79
Dopamine D2 receptors' effects on renal inflammation are mediated by regulation of PP2A function. Am J Physiol Renal Physiol (2015) 0.77
Role of nuclear factor erythroid 2-related factor 2 in the oxidative stress-dependent hypertension associated with the depletion of DJ-1. Hypertension (2015) 0.77
Gastrorenal Axis. Hypertension (2016) 0.76
Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells. Free Radic Res (2015) 0.76
Renal rescue of dopamine D2 receptor function reverses renal injury and high blood pressure. JCI Insight (2016) 0.75
Immunomodulatory Effects Mediated by Dopamine. J Immunol Res (2016) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
NF-kappaB regulation in the immune system. Nat Rev Immunol (2002) 15.80
Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol (2003) 10.29
Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med (2011) 8.54
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet (2003) 4.63
Interleukin-10: new perspectives on an old cytokine. Immunol Rev (2008) 3.94
Inflammation, immunity, and hypertension. Hypertension (2010) 3.43
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry (1999) 2.90
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteers. Mol Psychiatry (1998) 2.88
The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev (2003) 2.66
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
NF-kappaB in renal inflammation. J Am Soc Nephrol (2010) 2.00
Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res (2003) 1.88
Chemokines and chemokine receptors: an overview. Front Biosci (Landmark Ed) (2009) 1.87
Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl (2002) 1.65
Review article: the role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol (1999) 1.48
Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther (2004) 1.39
Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest (2011) 1.38
NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol (2008) 1.31
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol (2007) 1.21
Aldosterone antagonism or synthase inhibition reduces end-organ damage induced by treatment with angiotensin and high salt. Kidney Int (2009) 1.17
Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension (2006) 1.15
Dopamine and G protein-coupled receptor kinase 4 in the kidney: role in blood pressure regulation. Biochim Biophys Acta (2010) 1.13
Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a beta-adrenoceptor-mediated mechanism. J Neuroimmunol (2002) 1.12
Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both. J Neuroimmunol (2005) 1.10
Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension (2001) 1.09
Role for interactions between IP-10/Mig and CXCR3 in proliferative glomerulonephritis. J Am Soc Nephrol (1999) 1.02
Strategy for the development of a matched set of transport-competent, angiotensin receptor-deficient proximal tubule cell lines. In Vitro Cell Dev Biol Anim (2006) 1.02
Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol (2008) 1.00
Relationships between the taqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf) (2001) 1.00
Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. Int Immunopharmacol (2003) 0.99
Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis. J Histochem Cytochem (2008) 0.98
An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. Int J Cardiol (2005) 0.97
Intrarenal dopamine modulates progressive angiotensin II-mediated renal injury. Am J Physiol Renal Physiol (2011) 0.95
Role of chemokines for the localization of leukocyte subsets in the kidney. Semin Nephrol (2007) 0.95
Association of dopaminergic pathway gene polymorphisms with chronic renal insufficiency among Asian Indians with type-2 diabetes. BMC Genet (2008) 0.92
Requirement of Gbetagamma and c-Src in D2 dopamine receptor-mediated nuclear factor-kappaB activation. Mol Pharmacol (2003) 0.92
Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF-alpha release in vitro from activated rat mast cells. Exp Eye Res (2006) 0.91
Involvement of tumor necrosis factor-alpha in natriuretic response to systemic infusion of nitric oxide synthase inhibitor in anesthetized mice. Am J Physiol Renal Physiol (2010) 0.91
Regulation of Th2 cytokine gene transcription. Chem Immunol (2000) 0.91
Differential effects of angiotensin II type-1 receptor antisense oligonucleotides on renal function in spontaneously hypertensive rats. Hypertension (2005) 0.91
Effects of dopexamine on the intestinal microvascular blood flow and leukocyte activation in a sepsis model in rats. Crit Care (2006) 0.87
Modulation of the inflammatory response to cardiopulmonary bypass by dopexamine and epidural anesthesia. Acta Anaesthesiol Scand (2002) 0.87
Amphetamine-evoked c-fos mRNA expression in the caudate-putamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context. J Neurochem (2003) 0.87
Transcriptional regulation of Th2 cell differentiation. Immunol Cell Biol (2010) 0.86
Dopamine treatment in brain-dead rats mediates anti-inflammatory effects: the role of hemodynamic stabilization and D-receptor stimulation. Transpl Int (2007) 0.85
Polymorphism in exon 6 of the dopamine D(2) receptor gene (DRD2) is associated with elevated blood pressure and personality disorders in men. J Hum Hypertens (2001) 0.85
Differential regulation of NF-kappaB, SRE and CRE by dopamine D1 and D2 receptors in transfected NG108-15 cells. J Neurochem (2003) 0.84
Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin Exp Immunol (1994) 0.83
Proximal tubule cells stimulated by lipopolysaccharide inhibit macrophage activation. Kidney Int (2004) 0.82
Anti-inflammatory activity of pergolide, a dopamine receptor agonist. J Pharmacol Exp Ther (1991) 0.81
Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int (2008) 0.79
Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis. Cytokine (1997) 0.78
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
Genome sequence and analysis of the tuber crop potato. Nature (2011) 7.77
Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nat Genet (2002) 5.37
Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol (2006) 5.00
Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol (2008) 3.13
The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis (2004) 2.86
Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci U S A (2004) 2.83
MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol (2011) 2.59
Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer (2006) 2.36
Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer. Cancer Res (2010) 2.27
Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat (2006) 2.26
Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol (2006) 2.26
Short telomeres and prognosis of hypertension in a chinese population. Hypertension (2009) 2.18
The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol (2007) 2.13
Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci (2011) 2.11
Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension (2006) 2.05
c-Maf regulates IL-10 expression during Th17 polarization. J Immunol (2009) 1.99
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol (2005) 1.96
G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A (2002) 1.87
Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans. Blood (2012) 1.85
Multilocus analysis of hypertension: a hierarchical approach. Hum Hered (2004) 1.82
Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics (2011) 1.81
Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. Dev Cell (2010) 1.79
Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys (2006) 1.77
The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol Pharmacol (2005) 1.75
SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS One (2011) 1.70
Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice. Circulation (2005) 1.69
Perivascular support of human hematopoietic stem/progenitor cells. Blood (2013) 1.67
CTLA4 blockade broadens the peripheral T-cell receptor repertoire. Clin Cancer Res (2014) 1.66
Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol (2005) 1.64
Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions. Kidney Int (2008) 1.63
Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan. Antimicrob Agents Chemother (2012) 1.60
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol (2010) 1.60
Gastrin and D1 dopamine receptor interact to induce natriuresis and diuresis. Hypertension (2013) 1.57
Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice. J Clin Invest (2010) 1.55
Salvage-targeted kidney cancer therapy in patients progressing on high-dose interleukin-2 immunotherapy: the UCLA experience. Cancer J (2013) 1.52
A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol (2010) 1.51
Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem (2006) 1.51
Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol (2014) 1.50
RhoA modulates Smad signaling during transforming growth factor-beta-induced smooth muscle differentiation. J Biol Chem (2005) 1.48
Tubulocystic carcinoma of the kidney: clinicopathologic and molecular characterization. Am J Surg Pathol (2008) 1.47
Enhanced de novo assembly of high throughput pyrosequencing data using whole genome mapping. PLoS One (2013) 1.42
Mucinous carcinoma of the skin, primary, and secondary: a clinicopathologic study of 63 cases with emphasis on the morphologic spectrum of primary cutaneous forms: homologies with mucinous lesions in the breast. Am J Surg Pathol (2005) 1.42
Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem Biophys Res Commun (2011) 1.41
Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat Clin Pract Nephrol (2006) 1.40
Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney. Hypertens Res (2011) 1.40
Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency. J Clin Invest (2017) 1.39
Intercropping competition between apple trees and crops in agroforestry systems on the Loess Plateau of China. PLoS One (2013) 1.39
PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer. PLoS One (2013) 1.39
Long-term outcomes after endovascular abdominal aortic aneurysm repair: the first decade. Ann Surg (2006) 1.38
ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J (2006) 1.38
A three-step proteolytic cascade mediates the activation of the peptidoglycan-induced toll pathway in an insect. J Biol Chem (2008) 1.37
Anal HPV infection in HIV-positive men who have sex with men from China. PLoS One (2010) 1.37
A two-stage linkage analysis of Chinese schizophrenia pedigrees in 10 target chromosomes. Biochem Biophys Res Commun (2006) 1.37
Modulating microtubule stability enhances the cytotoxic response of cancer cells to Paclitaxel. Cancer Res (2011) 1.37
Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res (2006) 1.36
Functional genomics of the dopaminergic system in hypertension. Physiol Genomics (2004) 1.32
Human cortical distal nephron: distribution of electrolyte and water transport pathways. J Am Soc Nephrol (2002) 1.32
D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol (2006) 1.32
Liver-specific ablation of integrin-linked kinase in mice results in abnormal histology, enhanced cell proliferation, and hepatomegaly. Hepatology (2008) 1.31
Complete sequence of a duck astrovirus associated with fatal hepatitis in ducklings. J Gen Virol (2009) 1.31
Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1. Gut (2010) 1.31
Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells. J Clin Invest (2008) 1.31
Efficacy and pharmacokinetic/pharmacodynamic evaluation of the Aurora kinase A inhibitor MLN8237 against preclinical models of pediatric cancer. Cancer Chemother Pharmacol (2011) 1.30
Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension (2012) 1.30
The association of sport performance with ACE and ACTN3 genetic polymorphisms: a systematic review and meta-analysis. PLoS One (2013) 1.29
D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int (2004) 1.28
An atlas of DNA methylomes in porcine adipose and muscle tissues. Nat Commun (2012) 1.28
Increased noncanonical splicing of autoantigen transcripts provides the structural basis for expression of untolerized epitopes. J Allergy Clin Immunol (2004) 1.27
Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci (2002) 1.25
catena-Poly[[bis-(μ-2-formyl-6-meth-oxy-phenolato)copper(II)sodium]-μ-nitrato]. Acta Crystallogr Sect E Struct Rep Online (2011) 1.25
Lactation-related microRNA expression profiles of porcine breast milk exosomes. PLoS One (2012) 1.24
Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev Biol (2003) 1.24
Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications. BMC Cancer (2009) 1.23
Time course of renal Na-K-ATPase, NHE3, NKCC2, NCC, and ENaC abundance changes with dietary NaCl restriction. Am J Physiol Renal Physiol (2002) 1.23
Exaggerated adrenomedullary response to immobilization in mice with targeted disruption of the serotonin transporter gene. Endocrinology (2002) 1.23
Amelioration of genetic hypertension by suppression of renal G protein-coupled receptor kinase type 4 expression. Hypertension (2006) 1.22
β-globin gene transfer to human bone marrow for sickle cell disease. J Clin Invest (2013) 1.22
Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension (2005) 1.22
Genetics of salt-sensitive hypertension. Curr Hypertens Rep (2011) 1.21